Rights and permissions
About this article
Cite this article
Cost implications of end-stage liver disease without transplantation. Pharmacoecon. Outcomes News 123, 10 (1997). https://doi.org/10.1007/BF03271860
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271860